SARS-CoV-2 receptor ‘mimic' could prevent COVID-19
Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people’s cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.
No hay comentarios:
Publicar un comentario